Ignite Creation Date:
2024-05-06 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06178991
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-06
First Post:
2023-12-20
Brief Title:
A Study to Evaluate the Safety Tolerability and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza
Sponsor:
BioNTech SE
Organization:
BioNTech SE
Organization Data
Organization:
BioNTech SE
Class:
INDUSTRY
Study ID:
C5261002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioNTech SE
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |